Concord Medical Services, which leases radiotherapy and diagnostic imaging equipment to cancer centers in China, raised $132 million by offering 12,000,000 shares at $11.00, within the range of $9.50 to $11.50. Concord Medical Services plans to list on the NYSE under the symbol "CCM". Morgan Stanley, J.P. Morgan, and CICC acted as lead managers on the deal.
